Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.
This article is from
The Cancer Letter
archive.
Vol. 33 No. 29 | July 27, 2007
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Four Win 1988 General Motors Cancer Prizes
June 17, 1988
TCL Archive
Two Phase III Afatinib Trials Demonstrate Prolonged Survival
May 30, 2014
TCL Archive
Data-Dredging? Don’t Try It, FDA Says.
May 11, 2007
TCL Archive
NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC
June 21, 2002
TCL Archive
Waxman Subcommittee Hears Support For Cancer Act Renewal
March 7, 1980
TCL Archive
Missouri Continues Breast Screening, Adds Other Tests
July 9, 1982